Skip to main content

25 publications

Name Date Type Actions

Monthly information regarding the total number of voting rights and shares making of the share capital - December 2019

06/01/2020 Voting rights

2019 sales: €396.0 million (Up 7.6%)

The Vetoquinol Group posted 2019 sales of €396.0 million, up 7.6% as reported and up 6.1% at constant exchange rates.

23/01/2020 Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital - January 2020

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

07/02/2020 Voting rights

Vetoquinol to acquire rights for Profender® and Drontal® from Elanco Animal Health for the European economic area and the UK

February 12 th , 2020 (Lure, France) - Vetoquinol has agreed terms to acquire the European Economic area and UK rights to Profender® and Drontal® product families from Elanco Animal Health.

12/02/2020 Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital - February 2020

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

04/03/2020 Voting rights

Covid-19: Vetoquinol donates masks to neighboring healthcare facilities

Vetoquinol S.A, the animal health laboratory based in Lure (70) has decided to donate more than 6000 masks to hospitals and associations in the region. This is a civic action to help, amongst others, hospitals in the Belfort Montbéliard, Vesoul and Saint-Rémy regions.

20/03/2020 Public releases

2019 annual results: group sales €396.0M, up 6.1% at constant exchange rates. Net income group share: €28.6M (7.2% of sales)

At its meeting on March 24, 2020, the Vetoquinol S.A. Board of Directors reviewed the Group results and approved the 2019 financial statements. The auditors have completed their audit of the financial statements and will shortly issue their report thereon.

26/03/2020 Public releases

Monthly information regarding the total number of voting rights and shares making of the share capital - MArch 2020

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

06/04/2020 Voting rights

Q1 2020 sales €103.4 million (Up 13.7%)

Vetoquinol Group sales for Q1 2020 amounted to €103.4 million, up 13.7% as reported and up 13.4% at constant exchange rates.

16/04/2020 Public releases

Availability of the 2019 universal registration document

Vetoquinol informs that it has filed its 2019 Universal Registration Document with the Autorité des Marchés Financiers (AMF) on April 23, 2020.

23/04/2020 Public releases